HomeAI · summaries
Storia in 4 fonti
Veradermics keeps ‘momentum going’ as baldness drug helps women with hair loss
The Phase 2 data exceeded expectations, lifting company shares as high as nearly $130 apiece and building the case for what may be the first pill specifically approved for female pattern hair loss.
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
Veradermics declares first efficacy win in women for hair loss drug
Veradermics' oral VDPHL01 shows first efficacy data in women, boosting hair count 22.7 hairs/cm² at 6 months; Phase 2/3 trial due 2027.
- ·
benzinga.com
Veradermics' Oral Hair Loss Drug For Women Shows Results In Just 2 Months - Veradermics (NYSE:MANE)
Veradermics reported positive phase 2 data for VDPHL01, showing hair growth and favorable safety in women with pattern hair loss.
